BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 32696127)

  • 1. The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre.
    Naspro R; Finati M; Roscigno M; Pellucchi F; La Croce G; Sodano M; Manica M; Chinaglia D; Da Pozzo LF
    World J Urol; 2021 Jun; 39(6):1917-1926. PubMed ID: 32696127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological outcomes of concomitant carcinoma in situ at radical cystectomy in pure urothelial bladder cancer and in histological variants.
    Naspro R; La Croce G; Finati M; Roscigno M; Pellucchi F; Sodano M; Manica M; Gianatti A; Da Pozzo LF
    Urol Oncol; 2022 Feb; 40(2):61.e9-61.e19. PubMed ID: 34334293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
    Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients.
    Moschini M; Shariat SF; Lucianò R; D'Andrea D; Foerster B; Abufaraj M; Bandini M; Dell'Oglio P; Damiano R; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
    Clin Genitourin Cancer; 2017 Aug; 15(4):e603-e607. PubMed ID: 28040422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
    Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    da Silva RD; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Chade D; Guglielmetti GB; Pycha A; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Zerbib M; Scherr DS; Shariat SF
    J Urol; 2013 Aug; 190(2):487-92. PubMed ID: 23395802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer.
    Lin-Brande M; Pearce SM; Ashrafi AN; Nazemi A; Burg ML; Ghodoussipour S; Miranda G; Djaladat H; Schuckman A; Daneshmand S
    Urology; 2019 Nov; 133():157-163. PubMed ID: 31421144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
    Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
    Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
    Marks P; Gild P; Soave A; Janisch F; Minner S; Engel O; Vetterlein MW; Shariat SF; Sauter G; Dahlem R; Fisch M; Rink M
    Surg Oncol; 2019 Mar; 28():208-213. PubMed ID: 30851902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
    Ge P; Wang ZC; Yu X; Lin J; He Q
    BMC Urol; 2015 May; 15():46. PubMed ID: 26025446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis.
    Wang JK; Boorjian SA; Cheville JC; Kim SP; Tarrell RF; Thapa P; Frank I
    World J Urol; 2012 Dec; 30(6):801-6. PubMed ID: 23132611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
    Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA
    Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Immediate Radical Cystectomy Necessary for All Patients with Non-Muscle-Invasive Micropapillary Bladder Cancer?
    Jackson BL; Mohammed A; Mayer N; Dormer J; Griffiths TR
    Urol Int; 2016; 96(1):32-8. PubMed ID: 25924623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
    Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
    Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sociodemographic and survival disparities for histologic variants of bladder cancer.
    Jue JS; Koru-Sengul T; Moore KJ; Miao F; Alameddine M; Nahar B; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
    Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
    J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?
    Kotb AF; Kovac E; Kassouf W; Chin J; Fradet Y; Izawa J; Estey E; Fairey A; Rendon R; Cagiannos I; Lacombe L; Lattouf JB; Bell D; Drachenberg D; Aprikian AG
    World J Urol; 2012 Dec; 30(6):761-7. PubMed ID: 22293934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.